Robertson Jenny — SEC Form 4 filings

SEC reporting owner CIK 1995009. 8 Form 4 filings on record with FilingPulse; latest filed 2025-11-20.

Transaction summary — filings shown

Covers all 8 filings on record, filed 2024-01-09 to 2025-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Lexeo Therapeutics, Inc. (LXEO)Chief Legal Officer86 legs · 7,239 sh · $49,8666

Form 4 filings — Robertson Jenny

FiledFormIssuerReported transactionsSource
2025-11-204Lexeo Therapeutics, Inc. (LXEO)Sale (S): 549 @ $9.27EDGAR
2025-10-174Lexeo Therapeutics, Inc. (LXEO)Grant/award (A): 9,900 @ $0 · Sale (S): 3,486 @ $8.94 · Sale (S): 40 @ $9.56EDGAR
2025-08-204Lexeo Therapeutics, Inc. (LXEO)Sale (S): 542 @ $4.67EDGAR
2025-05-204Lexeo Therapeutics, Inc. (LXEO)Sale (S): 521 @ $2.77EDGAR
2025-04-094Lexeo Therapeutics, Inc. (LXEO)Grant/award (A): 5,720 @ $2.61EDGAR
2025-02-214Lexeo Therapeutics, Inc. (LXEO)Sale (S): 2,101 @ $4.41EDGAR
2025-01-104Lexeo Therapeutics, Inc. (LXEO)Grant/award (A): 36,250 @ $0 · Grant/award (A): 72,500 (derivative) @ $0EDGAR
2024-01-094Lexeo Therapeutics, Inc. (LXEO)Grant/award (A): 23,750 @ $0 · Grant/award (A): 142,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1995009 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →